Analysts Anticipate Avantor, Inc. (NYSE:AVTR) Will Announce Quarterly Sales of $1.99 Billion

Brokerages predict that Avantor, Inc. (NYSE:AVTRGet Rating) will post $1.99 billion in sales for the current quarter, according to Zacks. Eight analysts have provided estimates for Avantor’s earnings, with the lowest sales estimate coming in at $1.96 billion and the highest estimate coming in at $2.01 billion. Avantor posted sales of $1.86 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 7%. The firm is expected to report its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Avantor will report full year sales of $7.96 billion for the current financial year, with estimates ranging from $7.92 billion to $8.02 billion. For the next year, analysts anticipate that the company will report sales of $8.48 billion, with estimates ranging from $8.37 billion to $8.65 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Avantor.

Avantor (NYSE:AVTRGet Rating) last posted its quarterly earnings results on Thursday, April 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.93 billion. Avantor had a net margin of 7.72% and a return on equity of 32.17%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.35 EPS.

A number of analysts have commented on the stock. Cowen dropped their price target on shares of Avantor from $50.00 to $44.00 in a research report on Tuesday, April 19th. Morgan Stanley dropped their price target on shares of Avantor from $46.00 to $43.00 and set an “overweight” rating on the stock in a research report on Monday, February 7th. William Blair restated an “outperform” rating on shares of Avantor in a research report on Friday, April 29th. Raymond James dropped their price target on shares of Avantor from $43.00 to $40.00 and set an “outperform” rating on the stock in a research report on Monday, April 18th. Finally, Citigroup downgraded shares of Avantor from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $48.00 to $38.00 in a report on Monday, April 4th. Two analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from, Avantor currently has a consensus rating of “Buy” and an average target price of $43.13.

In other news, EVP Gerard Brophy sold 2,027 shares of Avantor stock in a transaction that occurred on Tuesday, March 1st. The shares were sold at an average price of $34.47, for a total value of $69,870.69. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.60% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Capital Advisors Ltd. LLC bought a new stake in Avantor in the fourth quarter worth approximately $29,000. Bank of New Hampshire acquired a new stake in shares of Avantor in the first quarter worth $25,000. Byrne Asset Management LLC acquired a new stake in shares of Avantor in the fourth quarter worth $32,000. Quadrant Capital Group LLC lifted its stake in shares of Avantor by 297.2% in the fourth quarter. Quadrant Capital Group LLC now owns 977 shares of the company’s stock worth $41,000 after buying an additional 731 shares during the last quarter. Finally, Standard Family Office LLC acquired a new stake in shares of Avantor in the fourth quarter worth $50,000. 93.24% of the stock is currently owned by hedge funds and other institutional investors.

Avantor stock traded up $0.69 during midday trading on Thursday, reaching $31.33. 3,373,351 shares of the stock traded hands, compared to its average volume of 5,079,030. Avantor has a fifty-two week low of $28.64 and a fifty-two week high of $44.37. The firm has a market cap of $19.12 billion, a price-to-earnings ratio of 35.20, a PEG ratio of 0.64 and a beta of 1.53. The firm has a fifty day moving average price of $32.26 and a two-hundred day moving average price of $35.90. The company has a current ratio of 1.80, a quick ratio of 1.18 and a debt-to-equity ratio of 2.03.

Avantor Company Profile (Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Read More

Get a free copy of the Zacks research report on Avantor (AVTR)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with's FREE daily email newsletter.